Taiki Isei

发表论文 97 篇 · 总被引 1101 次 · h-index 17

代表论文

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study) (2021 · ESMO Open · 被引 59)
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients (2022 · European Journal of Cancer · 被引 44)
Systemic therapy for Asian patients with advanced BRAF V600 ‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan ( B‐CHECK‐RWD study) (2023 · Cancer Medicine · 被引 25)
Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study (2023 · JGH Open · 被引 15)
A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanoma (2022 · Cancer Science · 被引 14)
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study (2022 · PLoS ONE · 被引 13)